BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10753851)

  • 1. The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties.
    Redner RL; Chen JD; Rush EA; Li H; Pollock SL
    Blood; 2000 Apr; 95(8):2683-90. PubMed ID: 10753851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
    Redner RL; Rush EA; Faas S; Rudert WA; Corey SJ
    Blood; 1996 Feb; 87(3):882-6. PubMed ID: 8562957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
    Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways.
    Jansen JH; Mahfoudi A; Rambaud S; Lavau C; Wahli W; Dejean A
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7401-5. PubMed ID: 7638205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
    Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
    Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
    Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPM-RAR, not the RAR-NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation.
    Pollock SL; Rush EA; Redner RL
    Leuk Lymphoma; 2014 Jun; 55(6):1383-7. PubMed ID: 23927396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia.
    So CW; Dong S; So CK; Cheng GX; Huang QH; Chen SJ; Chan LC
    Leukemia; 2000 Jan; 14(1):77-83. PubMed ID: 10637480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.
    Chen Y; Li S; Zhou C; Li C; Ru K; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang B; Wang M; Wang J
    Blood; 2014 Aug; 124(6):936-45. PubMed ID: 24782508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NPM-RAR fusion protein associated with the t(5;17) variant of APL does not interact with PML.
    Rush EA; Schlesinger KW; Watkins SC; Redner RL
    Leuk Res; 2006 Aug; 30(8):979-86. PubMed ID: 16504291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
    Zhang JW; Wang JY; Chen SJ; Chen Z
    J Biosci; 2000 Sep; 25(3):275-84. PubMed ID: 11022230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion.
    Okazuka K; Masuko M; Seki Y; Hama H; Honma N; Furukawa T; Toba K; Kishi K; Aizawa Y
    Int J Hematol; 2007 Oct; 86(3):246-9. PubMed ID: 17988991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia.
    Côté S; Zhou D; Bianchini A; Nervi C; Gallagher RE; Miller WH
    Blood; 2000 Nov; 96(9):3200-8. PubMed ID: 11050004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.
    Chen Z; Guidez F; Rousselot P; Agadir A; Chen SJ; Wang ZY; Degos L; Zelent A; Waxman S; Chomienne C
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1178-82. PubMed ID: 8302850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
    Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
    Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
    Benedetti L; Levin AA; Scicchitano BM; Grignani F; Allenby G; Diverio D; Lo Coco F; Avvisati G; Ruthardt M; Adamo S; Pelicci PG; Nervi C
    Blood; 1997 Aug; 90(3):1175-85. PubMed ID: 9242550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.